Answer
The bictegravir component of Biktarvy is primarily metabolised by CYP3A and UGT1A1, as shown in in vitro phenotyping studies.
Sources for this answer
- Biktarvy 50 mg/200 mg/25 mg film-coated tabletsGilead Sciences Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 21Document updated
Sources checked